See what’s changing first. Know which accounts matter next.
Fundz catches funding rounds before they’re announced, and acquisitions, new executives, hiring shifts and contract wins as they happen. It weighs them against your ideal customer profile and delivers a ranked shortlist every morning, with the evidence, the reason to reach out and the decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Anupam Rasayan India
Acquired Company
Bliss GVS Pharma Limited
Description
Anupam Rasayan India Limited has agreed to acquire a 43.30% stake in Bliss GVS Pharma Limited for ₹1,369.51 crore. This acquisition involves purchasing equity shares from the promoter group members and public shareholders, with a total transaction value of approximately ₹2,198.54 crore for up to 74.20% equity. The acquisition aims to enhance Anupam Rasayan's presence in the pharmaceutical sector.
Fundz sees it the moment Anupam Rasayan India makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Bliss GVS Pharma Limited?
Bliss GVS Pharma Limited was acquired by Anupam Rasayan India, based in Sachin. The deal was reported on September 27, 2026. Anupam Rasayan India Limited® is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India. Anupam Rasayan India is privately held and operates in Manufacturing.
When did Anupam Rasayan India acquire Bliss GVS Pharma Limited?
Anupam Rasayan India's acquisition of Bliss GVS Pharma Limited was reported on September 27, 2026. Anupam Rasayan India Limited has agreed to acquire a 43.30% stake in Bliss GVS Pharma Limited for ₹1,369.51 crore. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Bliss GVS Pharma Limited do?
Bliss GVS Pharma Limited is an established player in the pharmaceutical manufacturing sector, specializing in niche dosage forms. The company has a significant international presence, serving over 60 countries. It is privately held, operating in Manufacturing, and is based in Mumbai.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.